Heterogeneous Pattern of Dependence on Anti-Apoptotic BCL-2 Family Proteins upon CHOP Treatment in Diffuse Large B-Cell Lymphoma

Expression of the anti-apoptotic B-cell lymphoma 2 (BCL-2) protein in patients with diffuse large B-cell lymphoma (DLBCL) strongly correlates with resistance to standard therapy with cyclophosphamide, vincristine, doxorubicin, prednisolone, and rituximab (R-CHOP). Although studies focus mainly on th...

Descripción completa

Detalles Bibliográficos
Autores principales: de Jong, Mathilde Rikje Willemijn, Langendonk, Myra, Reitsma, Bart, Nijland, Marcel, van den Berg, Anke, Ammatuna, Emanuele, Visser, Lydia, van Meerten, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928684/
https://www.ncbi.nlm.nih.gov/pubmed/31801186
http://dx.doi.org/10.3390/ijms20236036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928684/
https://www.ncbi.nlm.nih.gov/pubmed/31801186
http://dx.doi.org/10.3390/ijms20236036

Ejemplares similares